Form 4 for OTLK Outlook Therapeutics, Inc.
Accepted 2023-04-21 00:00:00 ET · period of report 2023-04-20 · accession 0001209191-23-025294 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-21 | 2023-04-20 | OTLK | Dagnon Terry | Chief Ops Off | S - Sale | $1.14 | -520.0K | 653.1K | -44% | -$592.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-20 | S | D | 520,000 | $1.14 | 653,058 | D | — | — | (F1) These shares were sold to cover taxes upon lapse of Issuer's repurchase right as to 75% of the shares as provided in that certain Consulting Agreement dated January 27, 2020. |